|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.216
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.195
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.154
|
|
|
|
mrna processing
|
GO:0006397 |
63 |
0.135
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.132
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.123
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.119
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.117
|
|
|
|
dna templated transcription termination
|
GO:0006353 |
4 |
0.108
|
|
|
|
mrna metabolic process
|
GO:0016071 |
84 |
0.105
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.099
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.097
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.090
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.082
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.080
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.079
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.073
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.072
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.071
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.071
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.069
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.067
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.067
|
|
|
|
transcription from rna polymerase i promoter
|
GO:0006360 |
13 |
0.066
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.065
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.065
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.063
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.059
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.058
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.057
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.057
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.056
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.055
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.053
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.052
|
|
|
|
rna splicing via transesterification reactions
|
GO:0000375 |
43 |
0.052
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.051
|
|
|
|
oocyte anterior posterior axis specification
|
GO:0007314 |
2 |
0.050
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.049
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.047
|
|
|
|
secretory granule organization
|
GO:0033363 |
20 |
0.047
|
|
|
|
mrna splicing via spliceosome
|
GO:0000398 |
43 |
0.045
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.045
|
|
|
|
regulation of mrna processing
|
GO:0050684 |
41 |
0.045
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.045
|
|
|
|
ribonucleoprotein complex subunit organization
|
GO:0071826 |
28 |
0.045
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.044
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.044
|
|
|
|
nucleus organization
|
GO:0006997 |
45 |
0.043
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.043
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.042
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.041
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.041
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.041
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.041
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.039
|
|
|
|
positive regulation of cysteine type endopeptidase activity
|
GO:2001056 |
39 |
0.039
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.039
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.039
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.038
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.038
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.038
|
|
|
|
hepatocyte growth factor receptor signaling pathway
|
GO:0048012 |
3 |
0.038
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.038
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.037
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.037
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.037
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.037
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.036
|
|
|
|
protein polyubiquitination
|
GO:0000209 |
33 |
0.035
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.035
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.035
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.034
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.033
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.033
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.032
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.032
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.032
|
|
|
|
intracellular mrna localization
|
GO:0008298 |
4 |
0.032
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.031
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.031
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.031
|
|
|
|
cellularization
|
GO:0007349 |
1 |
0.030
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.030
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.030
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.030
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.030
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.029
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.029
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.029
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.029
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.029
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.029
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.028
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.028
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.028
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.028
|
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.028
|
|
|
|
negative regulation of platelet derived growth factor receptor signaling pathway
|
GO:0010642 |
7 |
0.028
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.028
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.028
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.027
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.026
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.026
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.026
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.026
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.026
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.026
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.025
|
|
|
|
termination of rna polymerase ii transcription
|
GO:0006369 |
1 |
0.025
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.025
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.025
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.024
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.024
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.024
|
|
|
|
negative regulation of cell morphogenesis involved in differentiation
|
GO:0010771 |
48 |
0.024
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.024
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.024
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.023
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.023
|
|
|
|
ribosomal small subunit biogenesis
|
GO:0042274 |
4 |
0.023
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.023
|
|
|
|
negative regulation of cell growth
|
GO:0030308 |
44 |
0.023
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.023
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.022
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.022
|
|
|
|
negative regulation of cell projection organization
|
GO:0031345 |
56 |
0.022
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.022
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.022
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.022
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.022
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.022
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.022
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.022
|
|
|
|
negative regulation of dna replication
|
GO:0008156 |
4 |
0.022
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.022
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.021
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.021
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.021
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.021
|
|
|
|
regulation of lipid storage
|
GO:0010883 |
20 |
0.021
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.021
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.021
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.020
|
|
|
|
photoreceptor cell morphogenesis
|
GO:0008594 |
3 |
0.020
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.020
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.020
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.020
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.020
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.020
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.020
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.020
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.020
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.019
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.019
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.019
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.019
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.019
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.018
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.018
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.018
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.018
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.018
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.018
|
|
|
|
rna splicing via transesterification reactions with bulged adenosine as nucleophile
|
GO:0000377 |
43 |
0.017
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.017
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.017
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.017
|
|
|
|
regulation of protein stability
|
GO:0031647 |
52 |
0.017
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.017
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.017
|
|
|
|
rna splicing
|
GO:0008380 |
54 |
0.017
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.017
|
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.016
|
|
|
|
maternal determination of anterior posterior axis embryo
|
GO:0008358 |
2 |
0.016
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.016
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.016
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.016
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.016
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.016
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.016
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.015
|
|
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
51 |
0.015
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.015
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.015
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.015
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.015
|
|
|
|
histone monoubiquitination
|
GO:0010390 |
3 |
0.015
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.015
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.015
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.015
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.015
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.015
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.014
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.014
|
|
|
|
establishment or maintenance of microtubule cytoskeleton polarity
|
GO:0030951 |
1 |
0.014
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.014
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.014
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.014
|
|
|
|
negative regulation of tyrosine phosphorylation of stat5 protein
|
GO:0042524 |
2 |
0.014
|
|
|
|
dna replication
|
GO:0006260 |
52 |
0.014
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.014
|
|
|
|
negative regulation of neuron projection development
|
GO:0010977 |
50 |
0.014
|
|
|
|
regulation of mrna splicing via spliceosome
|
GO:0048024 |
32 |
0.014
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.014
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.014
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.014
|
|
|
|
regulation of circadian rhythm
|
GO:0042752 |
58 |
0.014
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.014
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.013
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.013
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.013
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.013
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.013
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.013
|
|
|
|
regulation of axon extension
|
GO:0030516 |
43 |
0.013
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.013
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.013
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.013
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.013
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.013
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.013
|
|
|
|
regulation of mrna metabolic process
|
GO:1903311 |
43 |
0.013
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.013
|
|
|
|
osteoclast differentiation
|
GO:0030316 |
62 |
0.013
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.013
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.013
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.013
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.013
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.013
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.012
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.012
|
|
|
|
protein complex disassembly
|
GO:0043241 |
40 |
0.012
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.012
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.012
|
|
|
|
regulation of g1 s transition of mitotic cell cycle
|
GO:2000045 |
35 |
0.012
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.012
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.012
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.012
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.012
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.012
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.012
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.012
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.012
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.012
|
|
|
|
dna templated transcription initiation
|
GO:0006352 |
13 |
0.012
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.012
|
|
|
|
positive regulation of cell cycle phase transition
|
GO:1901989 |
17 |
0.012
|
|
|
|
intrinsic apoptotic signaling pathway by p53 class mediator
|
GO:0072332 |
35 |
0.012
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.011
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.011
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.011
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.011
|
|
|
|
centrosome separation
|
GO:0051299 |
4 |
0.011
|
|
|
|
regulation of response to dna damage stimulus
|
GO:2001020 |
34 |
0.011
|
|
|
|
mrna destabilization
|
GO:0061157 |
4 |
0.011
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.011
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.011
|
|
|
|
regulation of interferon beta biosynthetic process
|
GO:0045357 |
4 |
0.011
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.011
|
|
|
|
positive regulation of sequestering of triglyceride
|
GO:0010890 |
4 |
0.011
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.011
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.011
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.011
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.011
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.011
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.011
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.011
|
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.011
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.010
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.010
|
|
|
|
erbb signaling pathway
|
GO:0038127 |
32 |
0.010
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.010
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.010
|
|
|
|
oocyte differentiation
|
GO:0009994 |
35 |
0.010
|
|
|
|
regulation of cell cycle g1 s phase transition
|
GO:1902806 |
35 |
0.010
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
58 |
0.010
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.010
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.010
|
|